These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20388630)

  • 1. Strict glycaemic control in diabetic patients with CKD or ESRD: beneficial or deadly?
    Schernthaner G; Ritz E; Schernthaner GH
    Nephrol Dial Transplant; 2010 Jul; 25(7):2044-7. PubMed ID: 20388630
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemoglobin A1c in hemodialysis patients: should one size fit all?
    Ix JH
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1539-41. PubMed ID: 20671219
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?
    Haneda M; Morikawa A
    Nephrol Dial Transplant; 2009 Feb; 24(2):338-41. PubMed ID: 19015168
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
    Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPP-4 Inhibitors in Diabetic Patients with Chronic Kidney Disease and End-Stage Kidney Disease on Dialysis in Clinical Practice.
    Abe M; Okada K
    Contrib Nephrol; 2015; 185():98-115. PubMed ID: 26023019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic control and burnt-out diabetes in ESRD.
    Kovesdy CP; Park JC; Kalantar-Zadeh K
    Semin Dial; 2010; 23(2):148-56. PubMed ID: 20374552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a U-shaped curve of A1c versus mortality?
    Bloomgarden ZT; Drexler A
    J Diabetes; 2012 Jun; 4(2):107-8. PubMed ID: 22443259
    [No Abstract]   [Full Text] [Related]  

  • 9. An interview with the authors of "Is there a U-shaped curve of A1c vs. mortality?".
    Bloomgarden Z; Drexler A
    J Diabetes; 2012 Jun; 4(2):109. PubMed ID: 22583822
    [No Abstract]   [Full Text] [Related]  

  • 10. Stringent glycaemic control prolongs survival in diabetic patients with end-stage renal disease on haemodialysis.
    Shima K; Komatsu M; Kawahara K; Minaguchi J; Kawashima S
    Nephrology (Carlton); 2010 Sep; 15(6):632-8. PubMed ID: 20883284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes: Risks of strict glycaemic control in diabetic nephropathy.
    de Borst MH; Navis G
    Nat Rev Nephrol; 2015 Jan; 11(1):5-6. PubMed ID: 25366044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Typ 2 diabetes: glucose centered therapy is obsolete].
    Reincke M; Seissler J
    MMW Fortschr Med; 2008 May; 150(18):26-7. PubMed ID: 18533604
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
    Oei E; Samad N; Visser A; Chowdhury TA; Fan SL
    Diabet Med; 2016 Sep; 33(9):e17-20. PubMed ID: 26470840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of very tight blood glucose control in type 2 diabetes.
    Home P
    BMJ; 2008 Mar; 336(7642):458-9. PubMed ID: 18309965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.
    Biesenbach G; Bodlaj G; Ebner S; Biesenbach P; Pieringer H
    Int Urol Nephrol; 2011 Dec; 43(4):1155-60. PubMed ID: 20640938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin in peritoneal dialysis: a pilot experience.
    Al-Hwiesh AK; Abdul-Rahman IS; El-Deen MA; Larbi E; Divino-Filho JC; Al-Mohanna FA; Gupta KL
    Perit Dial Int; 2014 Jun; 34(4):368-75. PubMed ID: 24584596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic control in diabetes.
    Herman W
    Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678
    [No Abstract]   [Full Text] [Related]  

  • 19. [New drugs for control of blood glucose in type 2 diabetes: summary of the NICE guidelines].
    Adler AI; Shaw EJ; Stokes T; Ruiz F
    Praxis (Bern 1994); 2009 Oct; 98(20):1161-3. PubMed ID: 19809980
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of teneligliptin: a novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes.
    Otsuki H; Kosaka T; Nakamura K; Shimomura F; Kuwahara Y; Tsukamoto T
    Int Urol Nephrol; 2014 Feb; 46(2):427-32. PubMed ID: 24014134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.